Former CDC Director Dr. Robert Redfield has revealed that a shocking 20% of his long COVID patients never actually contracted the virus but developed symptoms after receiving mRNA vaccines, raising serious liability questions for manufacturers shielded by decades-old legal protections.
Key Takeaways
- Dr. Robert Redfield claims 20% of his long COVID patients developed symptoms from mRNA vaccines despite never having COVID-19
- The former CDC Director explains that spike proteins produced by vaccines may persist in the body for months with no mechanism to remove them
- Congressman Paul Gosar has introduced legislation to remove liability shields protecting vaccine manufacturers from lawsuits
- Redfield advocates for class-action lawsuits against vaccine makers for injuries potentially caused by their products
- Current laws from 1986 make it nearly impossible for vaccine-injured individuals to hold manufacturers accountable
Revealing Clinical Observations From Former CDC Leadership
Dr. Robert Redfield, who served as CDC Director under President Trump, has made alarming claims based on his current medical practice. Working with long COVID patients regularly, Redfield has identified a concerning pattern that challenges the mainstream narrative about vaccine safety. His clinical observations suggest that a significant number of individuals suffering from what appears to be long COVID never actually contracted the virus itself, raising questions about the true source of their persistent symptoms.
“I spend, you know, two days a week in the clinic, and my clinic is largely [treating] long COVID. And of patients with long COVID-like symptoms, probably about 20 percent of them, never had COVID. They got it from the mRNA vaccine,” said Dr. Robert Redfield
This revelation directly contradicts the repeated assurances from public health officials and pharmaceutical companies that mRNA vaccines pose minimal long-term risks. Redfield’s statements carry particular weight given his extensive background in virology and his former leadership position at the nation’s top public health agency. His willingness to speak out against the prevailing narrative demonstrates a commitment to scientific integrity over political correctness.
Understanding The Mechanism Of Potential Harm
The fundamental issue with mRNA vaccines, according to Redfield, lies in their core mechanism of action. Unlike traditional vaccines that introduce weakened or inactivated pathogens, mRNA vaccines instruct body cells to manufacture spike proteins themselves. This process, while innovative, may have unforeseen consequences when the body cannot effectively eliminate these manufactured proteins. The persistence of these foreign proteins in the system could explain the long-term symptoms experienced by some vaccine recipients.
“When you give an mRNA vaccine, what you do is you give your body the [ribonucleic acid], which then turns your body into a factory to make spike protein. Unfortunately, we don’t have a way to get rid of the spike protein. It just decays over time. But that time may be measured in months,” said Dr. Robert Redfield
Redfield’s explanation provides a plausible biological mechanism for vaccine-induced long COVID symptoms. If spike proteins remain in the body for extended periods, they could potentially trigger ongoing inflammatory responses and autoimmune reactions similar to those seen in patients who contracted the actual virus. This raises serious questions about whether adequate long-term safety studies were conducted before the widespread administration of these novel vaccines.
Legislative Push For Accountability
The current legal framework surrounding vaccines presents a significant barrier to those seeking compensation for injuries. Since 1986, vaccine manufacturers have enjoyed extraordinary legal protections that shield them from liability for adverse effects of their products. This special carve-out for pharmaceutical companies has created a situation where injured parties face nearly insurmountable obstacles in their pursuit of justice. Recognizing this fundamental unfairness, Congressman Paul Gosar has taken action to restore accountability.
“under current law, it is nearly impossible to hold vaccine manufacturers liable for injuries caused by vaccines due to a1986 law that unfairly created a special immunity carveout for Big Pharma, making it very difficult for vaccine-injured victims to win in a court of law,” said Congressman Paul Gosar
Gosar’s proposed legislation aims to level the playing field by removing these extraordinary protections and subjecting vaccine manufacturers to the same liability standards as other medical product companies. This push for accountability aligns with Redfield’s call for class-action lawsuits against manufacturers of mRNA vaccines. Both the former CDC director and the congressman recognize that when pharmaceutical companies face no financial consequences for harmful products, they have reduced incentives to ensure rigorous safety testing and transparent reporting of adverse events.
Implications For Public Health Policy
The revelations from Dr. Redfield and the legislative efforts by Congressman Gosar represent a significant challenge to the current vaccine policy paradigm. If a substantial portion of long COVID cases are actually vaccine injuries, this would necessitate a fundamental reassessment of the risk-benefit calculations that guided pandemic response policies. The aggressive push for universal vaccination, including for low-risk populations, may need to be reconsidered in light of these emerging concerns about long-term adverse effects.
President Trump’s Operation Warp Speed successfully delivered vaccines in record time, but the rush to market may have come with unforeseen consequences that we’re only now beginning to understand. The appropriate response is not to abandon medical innovation but to restore proper accountability measures that ensure pharmaceutical companies thoroughly test their products and take financial responsibility when those products cause harm. Only through such accountability can we rebuild public trust in our health institutions.
